Loomis, Sayles & Company’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-41
| Closed | -$5K | – | 1016 |
|
|
2023
Q2 | $5K | Buy |
41
+13
| +46% | +$1.59K | ﹤0.01% | 864 |
|
|
2023
Q1 | $4K | Sell |
28
-107
| -79% | -$15.3K | ﹤0.01% | 918 |
|
|
2022
Q4 | $17K | Sell |
135
-3,071
| -96% | -$387K | ﹤0.01% | 736 |
|
|
2022
Q3 | $354K | Buy |
+3,206
| New | +$354K | ﹤0.01% | 440 |
|
|
2021
Q1 | – | Sell |
-72
| Closed | -$12K | – | 889 |
|
|
2020
Q4 | $12K | Buy |
+72
| New | +$12K | ﹤0.01% | 699 |
|